Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Role of Microglial M1/M2 Polarization in Relapse and Remission of Psychiatric Disorders and Diseases.
Pharmaceutical approval update.
Matrix metalloproteinases and their pathological upregulation in multiple sclerosis: an overview.
Bilateral optic neuritis associated with scrub typhus.
Should patients with optic neuritis be treated with steroids?
Periodic limb movements during REM sleep in multiple sclerosis: a previously undescribed entity.
What to make of cannabis and cognition in MS: In search of clarity amidst the haze.
Grammatical Class Effects Across Impaired Child and Adult Populations.
Use of the VH6-1 gene segment to code for anti-interleukin-18 autoantibodies in multiple sclerosis.
Correction: Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
Neuroprotective Effects of Endurance Exercise against High Fat Diet-Induced Hippocampal Neuroinflammation.
A personalized, intense physical rehabilitation program improves walking in people with multiple sclerosis presenting with different levels of disability: a retrospective cohort.
New discovery rarely runs smooth: an update on progranulin/TNFR interactions.
Dehydrodiconiferyl alcohol (DHCA) modulates the differentiation of Th17 and Th1 cells and suppresses experimental autoimmune encephalomyelitis.
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis.
Nervous system involvement of connective tissue disease: mechanisms and diagnostic approach.
Reply: Shared environmental effects on multiple sclerosis susceptibility: conflicting evidence from twin studies.
Type I interferon in human autoimmunity.
Characteristics, diagnosis and outcome of patients referred to a specialized neurology emergency clinic: prospective observational study.
Assessing humoral immunocompetence after alemtuzumab treatment in MS.
Evaluation of plaque detection and optimum time of enhancement in acute attack multiple sclerosis after contrast injection.
Anti-Aquaporin-1 Autoantibodies in Patients with Neuromyelitis Optica Spectrum Disorders.
Myeloproliferative neoplasms in five multiple sclerosis patients.
The Montreal Cognitive Assessment (MoCA) as a screening test for cognitive dysfunction in multiple sclerosis.
Detection of Antibodies against Human and Plant Aquaporins in Patients with Multiple Sclerosis.
Pages
« first
‹ previous
…
676
677
678
679
680
681
682
683
684
…
next ›
last »